SequelSEC

BIOREGENX, INC. BRGX

Services-Computer Programming, Data Processing, Etc. · CIK 0001593184 · Fiscal year ends 1231

Revenue
$1.77M
Fiscal year ended 2026-03-31
Operating income
-$1.10M
Fiscal year ended 2026-03-31
Free cash flow
Unavailable
Fiscal year ended 2026-03-31

Valuation, from the filing

Public float$3.72MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.00Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Computer Programming, Data Processing, Etc. filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
SBC / revenue0.0%0th
Current ratio0.06x9th
R&D / revenue1.7%11th
Revenue YoY growth-20.8%12th
Net margin-83.2%18th
Operating margin-67.1%24th
Gross margin81.1%74th
FCF margin1.6%30th
CapEx / revenue0.5%31th

BIOREGENX, INC. (BRGX) reported revenue of $1.77M and net income of -$1.30M for the fiscal year ended 2026-03-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BIOREGENX, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Programming, Data Processing, Etc..

Income

BIOREGENX, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Revenue$1.77M
Cost of revenue$319.62K
Gross profit$1.45M
Operating income-$1.10M
Net income-$1.30M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$1.84M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

BIOREGENX, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Cash & equivalentsUnavailable
Total assets$337.07K
Current assets$190.29K
Total liabilities$4.87M
Current liabilities$3.99M
Total equity incl. NCI-$4.53M
Temporary (mezzanine) equityUnavailable
Inventory$92.81K
Accounts receivable$18.38K
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$698.97K

Cash flow

BIOREGENX, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Operating cash flow$27.91K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow-$6.69K
Net change in cash-$37.82K
Stock-based compensation$6.78K
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

BIOREGENX, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-31
Free cash flowUnavailable
Gross margin81.9%
Operating margin-62.4%
FCF marginUnavailable
SBC / revenue0.4%
Current ratio0.05x
Revenue YoY growth-23.4%
Net margin-73.8%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BRGX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-05-20View SEC filing
10-K · Filed 2026-04-15View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K/A · Filed 2025-04-16View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.